KSI-301 (tarcocimab tedromer) therapy of Retinal Vein Occlusion
Retina Synthesis - Un pódcast de Retina Synthesis
Categorías:
We discuss a phase 2/3 trial employing tarcocimab reformer for branch and central vein occlusion with Michael Singer, MD, Clinical Professor University of Texas San Antonio Health Sciences Center.
